on PHAXIAM THERAPEUTICS (isin : FR001400K4B1)
PHAXIAM announces the terms and conditions for making preparatory documents available for the Combined General Meeting
PHAXIAM Therapeutics has announced the terms and conditions for making preparatory documents available for the Combined General Meeting of June 28, 2024. The event will be held at 9:30 a.m. at the head office located 60 avenue Rockefeller in Lyon.
Shareholders can participate by attending the Meeting, by voting remotely via Votaccess or by giving a proxy. The documents, including the agenda and resolutions, are available on the company's website.
The notice of meeting and the notice of meeting were published in the Bulletin des Annonces Légales et Obligatoires respectively on May 22 and June 7, 2024.
PHAXIAM continues to keep shareholders informed via the dedicated section on its site, which will be updated according to legal requirements.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all PHAXIAM THERAPEUTICS news